New! Sign up for our free email newsletter.

Lymphoma News

June 25, 2025

Top Headlines

 

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly ...
A new gene editor may soon open the door to gene therapies for a wider array of ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form ...
Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study shows. The finding might help clinicians ...
A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory ...
Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting ...
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat ...
A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in ...
Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment ...

Latest Headlines

updated 11:44am EDT

Earlier Headlines

 

With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...

Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen. This is compared to 83% ...

Research has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say ...

Scientists have discovered why the flu vaccine can perform poorly. They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza response. ...

A 'loopy' discovery in bacteria is raising fundamental questions about the makeup of our own genome -- and revealing a potential wellspring of material for new genetic ...

Scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, ...

The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found ...

Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some ...

Recently, scientists found that some people who suffered from COVID-19 had auto-antibodies targeting their own type 1 interferons, which are important immune signaling proteins. Now, researchers ...

CAR-T cell therapies are transforming the treatment of previously incurable blood cancers, but a large proportion of patients still responds only poorly or not at all to them, calling for new ...

Scientists say they have developed an artificial lymph node with the potential to treat cancer, according to a new study in mice and human ...

A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of ...

A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...

Researchers have found a way to enhance and extend LN expansion, and study how this phenomenon affects both the immune system and efficacy of vaccinations against tumors. While the oversized LNs ...

Investigators have discovered how brain cells responsible for working memory -- the type required to remember a phone number long enough to dial it -- coordinate intentional focus and short-term ...

It is possible to leave most of the lymph nodes in the armpit, even if one or two of them have metastases larger than two millimeters. This is shown in a trial enrolling women from five countries. ...

A novel treatment for leukemias and lymphomas that arise from immune system T cells was found to be effective at killing these cancers in mice bearing human T-cell ...

Thursday, October 31, 2024

Wednesday, October 23, 2024

Thursday, October 17, 2024

Thursday, September 26, 2024

Friday, September 20, 2024

Monday, September 16, 2024

Tuesday, August 20, 2024

Friday, August 9, 2024

Monday, July 22, 2024

Thursday, June 20, 2024

Wednesday, June 19, 2024

Wednesday, June 12, 2024

Thursday, June 6, 2024

Thursday, May 30, 2024

Friday, May 17, 2024

Monday, May 6, 2024

Wednesday, April 17, 2024

Thursday, April 4, 2024

Tuesday, April 2, 2024

Tuesday, March 12, 2024

Wednesday, February 14, 2024

Friday, January 26, 2024

Wednesday, January 24, 2024

Wednesday, January 17, 2024

Monday, December 11, 2023

Thursday, November 16, 2023

Wednesday, November 15, 2023

Thursday, November 9, 2023

Monday, November 6, 2023

Friday, November 3, 2023

Thursday, November 2, 2023

Wednesday, September 13, 2023

Monday, September 11, 2023

Friday, September 1, 2023

Thursday, August 31, 2023

Thursday, August 17, 2023

Tuesday, August 8, 2023

Tuesday, July 18, 2023

Thursday, May 25, 2023

Monday, March 20, 2023

Thursday, March 2, 2023

Tuesday, February 21, 2023

Tuesday, February 14, 2023

Monday, February 13, 2023

Wednesday, February 1, 2023

Tuesday, January 24, 2023

Monday, January 9, 2023

Thursday, December 22, 2022

Wednesday, December 21, 2022

Tuesday, December 20, 2022

Monday, December 12, 2022

Tuesday, December 6, 2022

Wednesday, November 30, 2022

Tuesday, November 22, 2022

Thursday, November 17, 2022

Wednesday, November 16, 2022

Wednesday, November 9, 2022

Tuesday, November 8, 2022

Tuesday, November 1, 2022

Wednesday, October 26, 2022

Monday, October 17, 2022

Friday, October 14, 2022

Tuesday, October 4, 2022

Wednesday, September 21, 2022

Thursday, September 8, 2022

Wednesday, September 7, 2022

Tuesday, August 23, 2022

Thursday, August 18, 2022

Monday, August 15, 2022

Thursday, August 4, 2022

Friday, July 22, 2022

Thursday, July 21, 2022

Thursday, July 14, 2022

Wednesday, July 13, 2022

Monday, June 27, 2022